Literature DB >> 3322184

Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship.

M M Makos1, R D McComb, M N Hart, D R Bennett.   

Abstract

Glycogen deposition in vascular smooth muscle has been demonstrated previously in alpha-glucosidase deficiency but has not been clinically significant. Three sons of healthy, nonconsanguineous parents developed progressive proximal muscular weakness secondary to alpha-glucosidase deficiency. Each patient developed a fusiform basilar artery aneurysm, which was complicated by fatal rupture in two patients and a cerebellar infarction in the third. Postmortem examination demonstrated severe vacuolation of skeletal muscle, liver, and vascular smooth muscle with accumulation of periodic acid-Schiff-positive, diastase-sensitive material. In the surviving brother, similar glycogen deposition was demonstrated in the smooth muscle of the superficial temporal artery. Basilar artery aneurysm formation in this sibship may be a consequence of alpha-glucosidase deficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322184     DOI: 10.1002/ana.410220512

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  A report of two cases with dolichosegmental intracranial arteries as a new feature of PHACES syndrome.

Authors:  Carlos E Baccin; Timo Krings; Hortensia Alvarez; Augustin Ozanne; Pierre L Lasjaunias
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

2.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

Review 3.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

4.  Unusual case of subarachnoid haemorrhage in patient with Fabry's disease: case report and literature review.

Authors:  Michael T Cormican; Thanasis Paschalis; Angela Viers; Cargill H Alleyne
Journal:  BMJ Case Rep       Date:  2012-07-03

5.  Giant fusiform aneurysm of the vertebro-basilar artery presenting with stroke.

Authors:  F Ildan; E Cetinalp; H Bagdatoglu; B Boyar; Z Uzuneyüpoglu; A Karadayi
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

6.  Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.

Authors:  A Pichiecchio; S Sacco; P De Filippi; E Caverzasi; S Ravaglia; S Bastianello; C Danesino
Journal:  J Neurol       Date:  2017-08-30       Impact factor: 4.849

7.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

8.  Basilar artery aneurysm: a new finding in classic infantile Pompe disease.

Authors:  Trusha T Patel; Suhrad G Banugaria; Donald P Frush; David S Enterline; Pranoot Tanpaiboon; Priya S Kishnani
Journal:  Muscle Nerve       Date:  2013-02-10       Impact factor: 3.217

Review 9.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy.

Authors:  Paul T McIntosh; Lisa D Hobson-Webb; Zoheb B Kazi; Sean N Prater; Suhrad G Banugaria; Stephanie Austin; Raymond Wang; David S Enterline; Donald P Frush; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2017-10-13       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.